Evidence mapPaperPMID 36981518Full record

ArticleHealthcare (Basel, Switzerland)2023

Prevalence and Associated Risk Factors of Urinary Tract Infection among Diabetic Patients: A Cross-Sectional Study.

Anas Elyas Ahmed, Suhaila Abdelkarim, Maria Zenida, Maisa Ali Hussein Baiti, Atyaf Abbas Yahya Alhazmi, Bushra Ahmed Hussain Alfaifi, Rania Qarmoush Mohammed Majrabi, Nidaa Qasem M Khormi, Alyaj Alla Ali Hakami, Rafa Abdu Mohammed Alqaari and 8 more

Full text read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Comparative genomic analysis of uropathogenicFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Anas Elyas AhmedFaculty of Medicine, Jazan University, Jazan GGGD6622, Saudi Arabia.ORCID 0000-0001-8281-1373
Suhaila AbdelkarimFaculty of Medicine, Jazan University, Jazan GGGD6622, Saudi Arabia.ORCID 0000-0001-8625-6637
Maria ZenidaFaculty of Medicine, Jazan University, Jazan GGGD6622, Saudi Arabia.
Maisa Ali Hussein BaitiFaculty of Medicine, Jazan University, Jazan GGGD6622, Saudi Arabia.
Atyaf Abbas Yahya AlhazmiFaculty of Medicine, Jazan University, Jazan GGGD6622, Saudi Arabia.
Bushra Ahmed Hussain AlfaifiFaculty of Medicine, Jazan University, Jazan GGGD6622, Saudi Arabia.ORCID 0000-0001-5245-4520
Rania Qarmoush Mohammed MajrabiFaculty of Medicine, Jazan University, Jazan GGGD6622, Saudi Arabia.
Nidaa Qasem M KhormiFaculty of Medicine, Jazan University, Jazan GGGD6622, Saudi Arabia.
Alyaj Alla Ali HakamiFaculty of Medicine, Jazan University, Jazan GGGD6622, Saudi Arabia.
Rafa Abdu Mohammed AlqaariFaculty of Medicine, Jazan University, Jazan GGGD6622, Saudi Arabia.
Raffan Ahmed AlhasaniFaculty of Medicine, Jazan University, Jazan GGGD6622, Saudi Arabia.
Ramzi Abdu AlajamDepartment of Physical Therapy, College of Applied Medical Sciences, Jazan University, Jazan GGGD6622, Saudi Arabia.ORCID 0000-0001-5110-289X
Mohammed M AlshehriDepartment of Physical Therapy, College of Applied Medical Sciences, Jazan University, Jazan GGGD6622, Saudi Arabia.
Aqeel M AlenaziDepartment of Pharmaceutics, College of Pharmacy, Jazan University, Jazan GGGD6622, Saudi Arabia.ORCID 0000-0002-2641-8339
Bader AlqahtaniDepartment of Pharmaceutics, College of Pharmacy, Jazan University, Jazan GGGD6622, Saudi Arabia.ORCID 0000-0002-8275-6906
Meshal AlshamraniDepartment of Pharmaceutics, College of Pharmacy, Jazan University, Jazan GGGD6622, Saudi Arabia.ORCID 0000-0002-0396-8653
Ahmed AlhowimelDepartment of Pharmaceutics, College of Pharmacy, Jazan University, Jazan GGGD6622, Saudi Arabia.
Siddig Ibrahim AbdelwahabMedical Research Centre, Jazan University, Jazan GGGD6622, Saudi Arabia.ORCID 0000-0002-6145-4466

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urinary tract infections (UTIs) are one of the most common long-term complications of diabetes mellitus (DM). Additionally, various factors, such as socio-demographics, type of DM, fasting blood glucose, regular diabetes monitoring, comorbid chronic diseases, HbA1c, body mass index (BMI), and duration of DM, are also thought to predispose individuals to developing UTIs more frequently when they have DM. This research aims to evaluate the risk factors for UTIs and their prevalence among people with DM in Saudi Arabia (KSA). This cross-sectional study was conducted among 440 adults with type 1, type 2, and gestational DM. The participants had to be at least 18 years old, of both genders, and had been suffering from DM for any period of time. A self-administered questionnaire was utilized to collect data on demographic characteristics, such as sex, age, height, weight, material state, education level, income, and clinical profiles of DM and UTI. The crude (COR) and adjusted odds ratios (AOR) were calculated using logistic regression in the IBM SPSS software. The incidence of types 1 and 2 DM and gestational diabetes reached 34.1, 60.9, and 5%, respectively. Most of the participants had first-degree relatives with DM (65.9%). UTI was common in 39.3% of participants. A chi-squared statistical analysis revealed that the frequency of UTI varied depending (χ2 = 5.176,

Indexed as

diabetes mellitusrisk factorsSaudi Arabiaurinary tract infections

Identifiers

PMID36981518
PMCPMC10048613

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read66
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.